Open AccessCardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease
Author(s) -
Hamid Moradi,
Domenic A. Sica,
Kamyar KalantarZadeh
Publication year - 2013
Publication title -
american journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 85
eISSN - 1421-9670
pISSN - 0250-8095
DOI - 10.1159/000351758
Subject(s) - medicine , azotemia , kidney disease , uremia , intensive care medicine , uremic toxins , adverse effect , acute kidney injury , disease , clinical trial , renal function
Retention of uremic toxins in patients with chronic kidney disease (CKD) negatively affects multiple organ systems, including the cardiovascular system, resulting in significant morbidity and mortality. Alleviation of the adverse effects of uremic toxins is an important priority in the management of CKD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom